Olaf Hardt R&D Reagents Miltenyi Biotec GmbH Biography Publications Institution JoVE Articles Olaf Hardt has not added a biography. If you are Olaf Hardt and would like to personalize this page please email our Author Liaison for assistance. Publications The Sialyl-glycolipid Stage-specific Embryonic Antigen 4 Marks a Subpopulation of Chemotherapy-resistant Breast Cancer Cells with Mesenchymal Features Breast Cancer Research : BCR. 2015 | Pubmed ID: 26607327 Transcriptional Pathways in CPGI2-Induced Adipocyte Progenitor Activation for Browning Frontiers in Endocrinology. 2015 | Pubmed ID: 26347713 Comparison Between Cold Plasma, Electrochemotherapy and Combined Therapy in a Melanoma Mouse Model Experimental Dermatology. Sep, 2013 | Pubmed ID: 23947672 Highly Sensitive Profiling of CD44+/CD24- Breast Cancer Stem Cells by Combining Global MRNA Amplification and Next Generation Sequencing: Evidence for a Hyperactive PI3K Pathway Cancer Letters. Dec, 2012 | Pubmed ID: 22771536 NeuroD1 Induces Terminal Neuronal Differentiation in Olfactory Neurogenesis Proceedings of the National Academy of Sciences of the United States of America. Jan, 2010 | Pubmed ID: 20080708 Gene Expression Analysis Defines Differences Between Region-specific GABAergic Neurons Molecular and Cellular Neurosciences. Nov, 2008 | Pubmed ID: 18725299 Characterization of Peptides Released from Mitochondria: Evidence for Constant Proteolysis and Peptide Efflux The Journal of Biological Chemistry. Jan, 2005 | Pubmed ID: 15556950 Истощение мышиных клеток из ксенотрансплантатов опухолей человека значительно улучшает Downstream Анализ клеток-мишеней David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Medicine
Истощение мышиных клеток из ксенотрансплантатов опухолей человека значительно улучшает Downstream Анализ клеток-мишеней David J. Agorku1, Stefan Tomiuk1, Kerstin Klingner2, Stefan Wild1, Silvia Rüberg1, Lisa Zatrieb1, Andreas Bosio1, Julia Schueler2, Olaf Hardt1 1R&D Reagents, Miltenyi Biotec GmbH, 2In vivo Tumorbiology, Oncotest GmbH JoVE 54259 Medicine